World Health Organization. Antimicrobial Resistance: Global Report on Surveillance. Switzerland: World Health Organization, 2014.
World Health Organization. The Evolving Threat of Antimicrobial Resistance: Options for Action. Geneva: World Health Organization, 2012.
Smith R, Coast J.
The true cost of antimicrobial resistance. British Medical Journal
2013; 346: f1493.
Liu YY, et al.
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. The Lancet Infectious Diseases
2016; 16: 161–168.
Holmes AH, et al.
Understanding the mechanisms and drivers of antimicrobial resistance. Lancet
2015; 387: 176–187.
Woolhouse M, et al.
Antimicrobial resistance in humans, livestock and the wider environment. Philosophical Transactions of the Royal Society of London B Biological Sciences
2015; 370: 20140083.
Singer RS, Williams-Nguyen J.
Human health impacts of antibiotic use in agriculture: a push for improved causal inference. Current Opinion in Microbiology
2014; 19: 1–8.
KPMG LLP. The Global Economic Impact of Anti-microbial Resistance. KPMG LLP, 2014.
Taylor J, et al.
Estimating the Economic Costs of Antimicrobial Resistance: Model and Results. Santa Monica, CA: RAND Corporation, 2014.
Chandy SJ, et al.
High cost burden and health consequences of antibiotic resistance: the price to pay. Journal of Infection in Developing Countries
2014; 8: 1096–1102.
Ashiru-Oredope D, Hopkins S, English Surveillance Programme for Antimicrobial Utilization Resistance Oversight Group. Antimicrobial stewardship: English surveillance programme for antimicrobial utilization and resistance (ESPAUR). Journal of Antimicrobial Chemotherapy
2013; 68: 2421–2423.
Blair JMA, et al.
Molecular mechanisms of antibiotic resistance. Nature Reviews Microbiology
2015; 13: 42–51.
Molecular mechanisms that confer antibacterial drug resistance. Nature
2000; 406: 775–781.
Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. Atlanta: Centers for Disease Control and Prevention, 2013.
Laxminarayan R, et al.
Antibiotic resistance – the need for global solutions. The Lancet Infectious Diseases
2013; 13: 1057–1098.
Goossens H, et al.
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet
2005; 365: 579–587.
Landers TF, et al.
A review of antibiotic use in food animals: perspective, policy, and potential. Public Health Reports
2012; 127: 4–22.
Antimicrobials in agriculture and the environment: reducing unncecessary use and waste. In: The Review on Antimicrobial Resistance. London: HM Government and the Wellcome Trust, 2015.
Krishnasamy V, Otte J, Silbergeld E.
Antimicrobial use in Chinese swine and broiler poultry production. Antimicrobial Resistance & Infection Control
2015; 4: 17.
McEwen SA, Fedorka-Cray PJ.
Antimicrobial use and resistance in animals. Clinical Infectious Diseases
2002; 34(Suppl. 3): S93–S106.
Bell BG, et al.
A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infectious Diseases
2014; 14: 13.
Finley RL, et al.
The scourge of antibiotic resistance: the important role of the environment. Clinical Infectious Diseases
2013; 57: 704–710.
ECDC (European Centre for Disease Prevention and Control), E.E.F.S.A.a.E.E.M.A. ECDC/EFSA/EMA first joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals. EFSA Journal
2015; 13: 4006.
Mather AE, et al.
An ecological approach to assessing the epidemiology of antimicrobial resistance in animal and human populations. Proceedings of the Royal Society B: Biological Sciences
2012; 279: 1630–1639.
Price LB, et al.
Staphylococcus aureus CC398: host adaptation and emergence of methicillin resistance in livestock. mBio
2012; 3: e00305–e00311.
Paterson GK, et al.
The newly described mecA homologue, mecALGA251, is present in methicillin-resistant Staphylococcus aureus isolates from a diverse range of host species. Journal of Antimicrobial Chemotherapy
2012; 67: 2809–2813.
Harrison EM, et al.
Whole genome sequencing identifies zoonotic transmission of MRSA isolates with the novel mecA homologue mecC. EMBO Molecular Medicine
2013; 5: 509–515.
Datta R, et al.
Confounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition. Antimicrobial Resistance & Infection Control
2014; 3: 19.
Schechner V, et al.
Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance. Clinical Microbiology Reviews
2013; 26: 289–307.
Lowder BV, et al.
Recent human-to-poultry host jump, adaptation, and pandemic spread of Staphylococcus aureus. Proceedings of the National Academy of Sciences of the United States of America
2009; 106: 19545–19550.
Voss A, et al.
Methicillin-resistant Staphylococcus aureus in pig farming. Emerging Infectious Diseases
2005; 11: 1965–1966.
Baptiste KE, et al.
Methicillin-resistant Staphylococci in companion animals. Emerging Infectious Diseases
2005; 11: 1942–1944.
Machado E, et al.
Antibiotic resistance integrons and extended-spectrum beta-lactamases among Enterobacteriaceae isolates recovered from chickens and swine in Portugal. Journal of Antimicrobial Chemotherapy
2008; 62: 296–302.
Doi Y, et al.
Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clinical Microbiology and Infection
2010; 16: 33–38.
de Been M, et al.
Dissemination of cephalosporin resistance genes between Escherichia coli strains from farm animals and humans by specific plasmid lineages. PLoS Genetics
2014; 10: e1004776.
Mather AE, et al.
Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium DT104 in different hosts. Science
2013; 341: 1514–1517.
Tacconelli E, et al.
STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship. BMJ Open
2016; 6: e010134.
Leopold SJ, et al.
Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review. Journal of Antimicrobial Chemotherapy
2014; 69: 2337–2353.
van Staa T-P, et al.
Pragmatic randomised trials using routine electronic health records: putting them to the test. British Medical Journal
2012; 344: e55.
Koser CU, Ellington MJ, Peacock SJ.
Whole-genome sequencing to control antimicrobial resistance. Trends in Genetics
2014; 30: 401–407.
Lopardo G, et al.
Antimicrobial stewardship program in a developing country: the epidemiological barrier. Revista Panamericana de Salud Publica
2011; 30: 667–668.
Aryee A, Price N.
Antimicrobial stewardship – can we afford to do without it?
British Journal of Clinical Pharmacology
2015; 79: 173–181.
Bebell LM, Muiru AN.
Antibiotic use and emerging resistance: how can resource-limited countries turn the tide?
2014; 9: 347–358.
Okeke IN, et al.
Diagnostics as essential tools for containing antibacterial resistance. Drug Resistance Updates
2011; 14: 95–106.
World Health Organization. Country Pharmaceutical Situations. Geneva, Switzerland:
World Health Organization, 2009.
Delepierre A, Gayot A, Carpentier A.
Update on counterfeit antibiotics worldwide; public health risks. Medecine et Maladies Infectieuses
2012; 42: 247–255.
Kelesidis T, et al.
Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. Journal of Antimicrobial Chemotherapy
2007; 60: 214–236.
Forrest GN, et al.
Use of Electronic health records and clinical decision support systems for antimicrobial stewardship. Clinical Infectious Diseases
2014; 59(Suppl. 3): S122–S133.
Pires dos Santos R, et al.
Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates. Infection Control and Hospital Epidemiology
2011; 32: 584–590.
Challenges of antibacterial discovery. Clinical Microbiology Reviews
2011; 24(1): 71–109.
Debono M, et al.
A21978C, a complex of new acidic peptide antibiotics: isolation, chemistry, and mass spectral structure elucidation. Journal of Antibiotics (Tokyo)
1987; 40: 761–777.
Tackling drug-resistant infections globally: final report and recommendations. In: The Review on Antimicrobial Resistance. London: HM Government and the Wellcome Trust, 2016.